Re-appointment of Mr. Davuluri Saharsh Rao (DIN: 02753145), as Whole Time Director, designated as Vice Chairman & Managing Director

Promoter Family Board EntryManagement Changes View source PDF Explain this filing

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-7.2%Reaction day

₹11899.00

prior close

₹11050.00

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+1.5%-8.7% vs market

Pharmaceuticals peers, median of 150sector+0.2%-7.4% vs sector

On the reaction day the stock moved 8.7 pts less than Nifty Smallcap 250 and 7.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

+0.9

15m

+2.5

30m

-0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-7.2+1.5-8.7+0.2-7.4

Next day

-5.5+2.2-7.7+1.1-6.6

-6.2+1.3-7.5+0.2-6.4

-6.1+1.7-7.8+1.0-7.1

-6.2+1.7-7.9+1.2-7.4

-6.6+2.3-8.9+0.7-7.4

-6.6+3.0-9.6+1.4-8.0

15d

+8.4+7.0+1.4+0.6+7.8

+7.4+7.0+0.4+2.1+5.4

+20.5+11.3+9.2+3.8+16.7

+13.5+4.5+9.0-1.0+14.4

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 150Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Neuland Laboratories reported audited FY25 (year ended March 31, 2025) results with consolidated revenue of Rs. 1,497.3 crores, down from Rs. 1,571.1 crores in FY24. Consolidated profit after tax stood at Rs. 260.1 crores vs Rs. 300.1 crores, with EPS at Rs. 202.74 vs Rs. 233.89. Statutory auditors MSKA & Associates issued an unmodified opinion. The board recommended a final dividend of Rs. 12 per share (120% on face value of Rs. 10), subject to shareholder approval at the 41st AGM on July 30, 2025. Mr. Davuluri Saharsh Rao was re-appointed as Whole Time Director designated Vice Chairman & Managing Director for a fresh 5-year term from June 1, 2025. The company also appointed P.S. Rao & Associates as secretarial auditors for 5 years (FY26–FY30).

Likely market impact

Core operations saw a revenue and profit dip year-on-year, though headline profit was lifted by a Rs. 76.4 crore exceptional gain from transferring an investment property via perpetual lease. The 120% dividend signals healthy cash flows and shareholder rewards despite operational softness. Re-appointment of a promoter family member (son of the Executive Chairman and brother of the CEO) ensures leadership continuity.